Please assess the completion status of the following clinical trial:

Trial Title: High-Density Spinal Cord Stimulation for the Treatment of Chronic Intractable Pain Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients with chronic intractable pain who meets the Korean SCS Reimbursement Guideline as follows:~   (Korea SCS Reimbursement Guideline)~  1. An ineffective patient with sustainable severe intractable pain (VAS or NRS pain score over 7 grade) who has been treated by a conservative therapy (medication and nerve block, etc.) for 6 months. cf.) CRPS is available after the conservative therapy for 3 months~  2. An ineffective cancer pain patient with over 1-year life expectancy and VAS (or NRS pain score) over 7 grade who takes active pain treatment for 6 months such as medication, nerve block, epidural morphine injection, etc.~2. Age \> 18~3. Patients who have been informed of the study procedures and has given written informed consent.~4. Patients who are willing to comply with study protocol including attending the study visits~Exclusion Criteria:~1. Expected inability of patients to receive or properly operate the SCS system~2. Active malignancy~3. Addiction to any of the following drugs, alcohol, and/or medication~4. Evidence of an active disruptive psychiatric disorder or other known condition significant enough to impact perception of pain, compliance to intervention and/or ability to evaluate treatment outcome as determined by investigator~5. Local infection or other skin disorder at site of incision~6. Pregnancy~7. Other implanted active medical device~8. Life expectancy \< 1 year~9. Coagulation deficiency (Platelet count \< 100,000, PT INR \> 1.4)~10. Immune deficiency (HIV positive, immunosuppressive, etc.)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group C spinal cord stimulator (Type: EXPERIMENTAL): Spinal cord stimulator (SCS) implantation with conventional stimulation mode therapy during 2 weeks followed by 2 weeks with high-density stimulation mode therapy.
- Group H spinal cord stimulator (Type: ACTIVE_COMPARATOR): Spinal cord stimulator (SCS) implantation with high-density stimulation mode therapy during 2 weeks followed by 2 weeks with conventional stimulation mode therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).